WesBanco Given New $28.00 Price Target at Janney Montgomery Scott (WSBC)

Share on StockTwits

Equities researchers at Janney Montgomery Scott upped their price objective on shares of WesBanco (NASDAQ: WSBC) from $27.00 to $28.00 in a research report issued on Monday, StockRatingsNetwork.com reports. Janney Montgomery Scott’s price target would indicate a potential upside of 11.78% from the stock’s previous close.

Shares of WesBanco (NASDAQ: WSBC) traded down 1.25% during mid-day trading on Monday, hitting $25.36. WesBanco has a 52 week low of $19.70 and a 52 week high of $24.85. The stock’s 50-day moving average is currently $23.76. The company has a market cap of $740.9 million and a P/E ratio of 13.20.

WSBC has been the subject of a number of other recent research reports. Analysts at Zacks upgraded shares of WesBanco from a “neutral” rating to an “outperform” rating in a research note to investors on Monday, April 29th. They now have a $26.10 price target on the stock. Separately, analysts at Keefe, Bruyette & Woods raised their price target on shares of WesBanco from $25.00 to $26.00 in a research note to investors on Friday, April 26th. They now have a “market perform” rating on the stock.

The company also recently announced a quarterly dividend, which is scheduled for Monday, July 1st. Stockholders of record on Friday, June 14th will be paid a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a dividend yield of 3.03%. The ex-dividend date is Wednesday, June 12th.

WesBanco, Inc. (NASDAQ: WSBC) is a bank holding company.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Latest News

One-Hour Delivery by Amazon Arrives in Seattle
One-Hour Delivery by Amazon Arrives in Seattle
Dangerous Bacteria in Ground Beef Shows Study
Dangerous Bacteria in Ground Beef Shows Study
Vital Therapies Stock Plunges Following Failed Trial For Liver Therapy
Vital Therapies Stock Plunges Following Failed Trial For Liver Therapy
Sears Reports Profit for the Quarter But Sales Drop
Sears Reports Profit for the Quarter But Sales Drop
Lenovo Sets Up Manufacturing Facility in India
Lenovo Sets Up Manufacturing Facility in India
AT&T Increases Data Plans for Mobile Users to Maintain Pace
AT&T Increases Data Plans for Mobile Users to Maintain Pace


Advertisement
Advertisement
© 2006-2015 Ticker Report. Google+.